GWM
LMAT icon

Geneos Wealth Management’s LeMaitre Vascular LMAT Stock Holding History

Geneos Wealth Management’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-551
Closed -$45.8K – 2882
2025
Q2 		$45.8K Sell
551
-6
-1% -$501 ﹤0.01% 1619
2025
Q1 		$46.7K Buy
557
+398
+250% +$37K ﹤0.01% 1510
2024
Q4 		$14.7K Buy
159
+11
+7% +$1.06K ﹤0.01% 1879
2024
Q3 		$13.7K Buy
+148
New +$12.8K ﹤0.01% 1709

Other funds holding LMAT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.36B AUM 17.81% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Geneos Wealth Management's LMAT Position: Q3 2025 in Review

Geneos Wealth Management sold out of LeMaitre Vascular (LMAT) in Q3 2025, closing a stake of 551 shares — an estimated $45.8K sold.

Geneos Wealth Management first reported a position in LMAT in Q3 2024 and held it in 4 quarters. The position peaked at $46.7K in Q1 2025. 297 funds tracked by Wall St. Rank hold LMAT as of Q3 2025.

  • Geneos Wealth Management reported no remaining LeMaitre Vascular position as of Q3 2025 after selling out during the quarter.
  • Geneos Wealth Management sold 551 LeMaitre Vascular shares in Q3 2025, an estimated $45.8K.
  • Geneos Wealth Management first reported a position in LeMaitre Vascular in Q3 2024 and held it in 4 quarters.
  • Geneos Wealth Management's LeMaitre Vascular position peaked at $46.7K in Q1 2025.
  • 297 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q3 2025.

Based on Geneos Wealth Management's 13F filing for Q3 2025, filed 22 Oct 2025.